Jeena Sikho Lifecare Ltd (JSLL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Jeena Sikho Lifecare Ltd on NSE and BSE, with an AI summary of each filing.
Approval for proposed Incorporation of a Subsidiary.
Others (Uncategorized) · 04 Nov 2026, 10:20 pm
Jeena Sikho Lifecare Approves Incorporation of New Subsidiary Ayugenomics Jeena Sikho Lifecare’s board approved the incorporation of a subsidiary in India, Ayugenomics Private Limited, on 4th Nov'26. The company will hold a 60% equity stake by subscribing to 30,000 equity shares at Rs. 10 each for a total cash consideration of Rs. 3,00,000. Ayugenomics will operate in Ayurveda and AYUSH systems, focusing on genomics-based research, diagnostics, AI clinical platforms, evidence-based nutraceuticals, and international commercialization. No governmental approvals are presently required for the incorporation.
Approval for the Proposed Incorporation of a Subsidiary
Others (Uncategorized) · 04 Nov 2026, 10:19 pm
Jeena Sikho Lifecare Approves Incorporation of New Subsidiary Ayugenomics Jeena Sikho Lifecare's Board approved incorporating a subsidiary in India, Ayugenomics Private Limited, on 4th Nov'26. The company will hold a 60% equity stake by subscribing to 30,000 equity shares of Rs 10 each for a total cash consideration of Rs 3,00,000. The proposed entity has an authorized share capital of Rs 5,00,000 and will focus on research, diagnostics, genomics, and clinical services integrated with Ayurveda and AYUSH systems, targeting global and domestic markets.
Jeena Sikho Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Prior Intimation of Board ....
Intimation · 14 Nov 2026, 5:30 am
Jeena Sikho Lifecare Schedules Board Meeting to Approve Q2 FY27 Results Jeena Sikho Lifecare Limited's Board of Directors is scheduled to meet on 14th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26, alongside the Limited Review Report. The trading window for designated persons and their immediate relatives has been closed since 1st Oct'26 and will remain shut until 48 hours following the declaration and submission of the financial results to stock exchanges.
JEENA SIKHO LIFECARE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 14 Nov 2026, 5:30 am
To consider and approve the Unaudited financial results (Standalone and Consolidated) for the period ended September 30, 2026
Intimation · 14 Nov 2026, 5:30 am
Allotment of 23,374 Equity Shares under the Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2024 ("ESOS 2024")
Others (Uncategorized) · 10 Oct 2026, 8:34 pm
Jeena Sikho Lifecare Approves Share Allotment Under ESOS 2024 Jeena Sikho Lifecare Limited approved the allotment of 23,374 equity shares with a face value of Rs. 2 each on 10th Oct'26, pursuant to the exercise of stock options under its ESOS 2024 scheme at an exercise price of Rs. 2 per share. Following this allotment, the company's paid-up equity share capital increased from Rs. 24,86,01,460 (12,43,00,730 shares) to Rs. 24,86,48,208 (12,43,24,104 shares). The newly allotted equity shares rank pari passu with the existing equity shares of the company.
Launch of New Products
Others (Uncategorized) · 06 Oct 2026, 12:05 am
Jeena Sikho Lifecare Launches New Ayurvedic and Nutraceutical Products Jeena Sikho Lifecare Limited launched eight new products across the Ayurvedic healthcare, wellness, and nutraceutical segments for the domestic market on 5th Oct'26. The launches comprise Acharya Ji Arogyam Vati, Acharya Ji Nirogyam Vati, Jod Xpert pain-relief range (oil, roll-on, and tablets), alongside three nutraceutical plant protein variants (General, Men, and Women) offered in chocolate, mango, and coffee flavors (500 Gm). The strategic expansion broadens the company’s wellness portfolio and deepens presence across high-demand preventive healthcare and dietary supplement categories in India.
NABH Accreditation for Raiput Hospital
Others (Uncategorized) · 02 Oct 2026, 12:13 am
Jeena Sikho Lifecare Secures NABH Accreditation for Raipur Hospital Jeena Sikho Lifecare Limited has received National Accreditation Board for Hospitals & Healthcare Providers (NABH) accreditation for its hospital located in Raipur, Chhattisgarh. The accreditation (Certificate No. AH-2026-0513) covers Panchakarma services and remains valid until 20th Aug'29. This certification validates the facility's compliance with nationally recognized standards for quality healthcare delivery, operational excellence, and patient safety in the ordinary course of business, with no impact on capacity expansion or acquisitions.
Scrutinizer''s Report and Voting Result of 9th AGM of the company Held on 28.09.2026
Annual General Meeting · 01 Oct 2026, 1:31 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavna Grover
Acquisition/ Disposal of Shares · 30 Sept 2026, 8:10 pm
Promoter Bhavna Grover Acquires 25,000 Equity Shares in Jeena Sikho Lifecare Jeena Sikho Lifecare Limited promoter Bhavna Grover acquired 25,000 equity shares (0.02% stake) via an open market purchase on 29th Sep'26. Following this transaction, her individual shareholding increased from 2,78,000 shares (0.22%) to 3,03,000 shares (0.24%). Consequently, the aggregate Promoter and Promoter Group holding in the company expanded from 63.62% to 63.66%. The company's total equity share capital remains unchanged at Rs 24.86 crore, comprising 12,43,00,730 equity shares of face value Rs 2 each.
Disclosure under Regulation 29(2), details as attached in the PDF.
Others (Uncategorized) · 30 Sept 2026, 6:42 pm
Jeena Sikho Lifecare Promoter Bhavna Grover Acquires 25,000 Equity Shares Jeena Sikho Lifecare Limited promoter and Whole Time Director Bhavna Grover acquired 25,000 equity shares (0.02% stake) via open market purchase on 29th Sep'26. Following the transaction, her individual holding increased from 2,78,000 shares (0.22%) to 3,03,000 shares (0.24%). Consequently, the aggregate promoter and promoter group shareholding rose from 63.62% to 63.66%. The company's total voting capital remains unchanged at Rs. 24,86,01,460 divided into 12,43,00,730 equity shares of Rs. 2 each.
Disclosure under Regulation 29(2), details as attached in the PDF.
Others (Uncategorized) · 29 Sept 2026, 6:52 pm
Jeena Sikho Lifecare Promoter Bhavna Grover Acquires Shares Via Open Market Jeena Sikho Lifecare Limited announced that promoter and Whole Time Director Bhavna Grover acquired 35,000 equity shares (0.02% stake) via an open market purchase on 28th Sep'26. Following the transaction, Grover's individual stake increased from 0.20% (2,43,000 shares) to 0.22% (2,78,000 shares). Consequently, the overall Promoter and Promoter Group shareholding in the company expanded from 63.62% to 63.64%. The company's total voting capital remains unchanged at Rs. 24.86 crore, comprising 12,43,00,730 equity shares of Rs. 2 each.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavna Grover
Acquisition/ Disposal of Shares · 29 Sept 2026, 6:52 pm
Promoter Bhavna Grover Acquires 35,000 Shares in Jeena Sikho Lifecare Promoter Bhavna Grover acquired 35,000 equity shares (a 0.02% stake) of Jeena Sikho Lifecare Limited via an open market purchase on 28th Sep'26. Following the transaction, her individual holding increased from 2,43,000 shares (0.20%) to 2,78,000 shares (0.22%). Consequently, the aggregate promoter and promoter group shareholding in the company expanded from 63.62% to 63.64%. The company's total voting capital remains unchanged at Rs. 24,86,01,460, comprising 12,43,00,730 equity shares of Rs. 2 each.
Proceedings of 9th AGM of the Company held on 28.09.2026
Annual General Meeting · 28 Sept 2026, 11:16 pm
Intimation of In-Principle Approval from BSE Limited under Jeena sikho Employees Stock Option Scheme, 2024 (ESOS 2024)
Others (Uncategorized) · 23 Sept 2026, 5:52 pm
Jeena Sikho Lifecare Receives BSE In-Principle Approval for ESOS 2024 Shares Jeena Sikho Lifecare Limited received in-principle approval from BSE on 22nd Sep'26 for listing up to 6,50,000 equity shares (face value ₹2 each) under its Employee Stock Option Scheme 2024 (ESOS 2024). The company previously secured approval from NSE on 14th Mar'24. Following a stock split from a face value of ₹10 to ₹2 per share, the original 1,30,000 approved shares were adjusted to 6,50,000 equity shares. The company now holds required listing approvals from both NSE and BSE for ESOS 2024 share issuances.
Intimation of Schedule of Analyst / Investor Meet/ Conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation · 23 Sept 2026, 12:27 am
Jeena Sikho Lifecare to Attend Bharat Connect Conference on 29th Sep'26 Jeena Sikho Lifecare Limited announced that its management will participate virtually in the "Bharat Connect Conference: Rising Stars – March 2026", organized by Arihant Capital Markets Limited, on 29th Sep'26 at 11:00 AM. The company confirmed that discussions will rely strictly on publicly available information, with no unpublished price-sensitive information (UPSI) to be shared during the interaction.
Launch of New products.
Others (Uncategorized) · 22 Sept 2026, 12:06 am
Jeena Sikho Lifecare Launches Two New Ayurvedic Healthcare Products Jeena Sikho Lifecare Limited launched two new Ayurvedic tablet products on 21st Sep'26: "Acharya Ji's Amrit Tattava Vati" (60 tablets) and "Acharya Ji's Oja Amrit Vati" (60 tablets). Both products are targeted exclusively at the domestic market. The launches are aimed at strengthening and expanding the company's existing portfolio of Ayurvedic healthcare and wellness offerings.
Please refer to the attached PDF for details.
Others (Uncategorized) · 09 Sept 2026, 8:05 pm
Jeena Sikho Lifecare Postpones Lucknow Hospital Facility Commercial Operations to Dec'26 Jeena Sikho Lifecare Limited announced a postponement in the commencement of commercial operations at its new hospital facility located at Kanpur Road, Lucknow, Uttar Pradesh. The commercial launch is now rescheduled for Dec'26, pending operational arrangements and premises readiness. The upcoming facility spans an estimated area of approximately 1.25 lakh sq. ft. and features an estimated capacity of 160+ beds.
Please refer to the attached PDF for details.
Others (Uncategorized) · 09 Sept 2026, 8:04 pm
Jeena Sikho Lifecare Postpones Ayodhya Day Care Clinic Launch to Late Sep'26 Jeena Sikho Lifecare Limited has announced a postponement in the commencement of commercial operations at its new Day Care Clinic in Ayodhya, Uttar Pradesh. Originally proposed via an intimation on 11th Jun'26, the facility—spanning approximately 2,300 sq. ft. on Ram Path Road—is now expected to begin operations towards the end of Sep'26. The delay is subject to the finalization of requisite operational arrangements and complete readiness of the clinic premises.
Receipt of NABH Accreditation for Pune Hospital.
Others (Uncategorized) · 08 Sept 2026, 10:02 pm
Jeena Sikho Lifecare Secures NABH Accreditation for Pune Hospital Jeena Sikho Lifecare Limited has been awarded NABH accreditation for Panchakarma services at its Pune hospital facility (Certificate No. AH-2026-0505), valid through 27th Jul'29. The accreditation recognizes adherence to quality healthcare delivery, patient safety, and operational excellence standards. Occurring in the ordinary course of business, the development validates clinical quality standards without constituting capacity enhancement, business expansion, or an acquisition.
Launch of New Products.
Others (Uncategorized) · 05 Sept 2026, 10:15 pm
Jeena Sikho Lifecare Launches Two New Ayurvedic Wellness Products Jeena Sikho Lifecare Limited announced the launch of two new Ayurvedic products on 5th Sep'26: Acharya Ji's Jeevanodya Vati (60 tablets) and Acharya Ji's Ojavardhan Vati (60 tablets). Both products belong to the tablet category and are introduced exclusively for the domestic market. The new launches aim to further strengthen and expand the company's existing portfolio within the Ayurvedic healthcare and wellness segments.
Please refer to the PDF attached
Annual General Meeting · 04 Sept 2026, 11:23 pm
Jeena Sikho Lifecare Dispatches 9th AGM Notice and FY26 Annual Report Links Jeena Sikho Lifecare Limited dispatched physical intimations containing web-links for its FY25-26 Integrated Annual Report and 9th Annual General Meeting (AGM) Notice to unregistered email shareholders as of the cut-off date, 28th Aug'26. The 9th AGM is scheduled for 28th Sep'26 at 12:00 PM IST in Zirakpur, Punjab. Additionally, the company reminded physical shareholders to complete mandatory KYC updates—including PAN, bank details, and nomination—and dematerialize shares in compliance with SEBI norms to remain eligible for electronic dividend and corporate payments.
Business Responsibility and Sustainability Report for Financial Year 2025-26
Others (Uncategorized) · 04 Sept 2026, 11:21 pm
Integrated Annual Report for Financial Year 2025-26
Others (Uncategorized) · 04 Sept 2026, 11:19 pm
Notice of the 9th Annual General Meeting scheduled to be held on 28th September, 2026 at 12:00 Noon.
Annual General Meeting · 04 Sept 2026, 11:01 pm